Marc Galiano
Research Subjects
Marc Galiano has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Xavier Cathelineau
Paris, France
18 shared publications F. Rozet
15 shared publicationsE. Barret
9 shared publicationsD. Prapotnich
7 shared publications- Eliza Barret
Department of Pharmacy, Bichat University Hospital, Paris, France
6 shared publications - Fernando P. Secin
San Lázaro Foundation and FUNDES, Buenos Aires, Argentina
6 shared publications
Latest Publications
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e251658
One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study
This multicenter study of 195 patients treated with MRI-directed, US-guided transperineal focal laser ablation revealed an in-field recurrence of clinically significant prostate cancer rate of 17% at the 1-year follow-up.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e251658
One-year Follow-up after US-guided Transperineal Focal Laser Ablation of Localized Prostate Cancer: Worldwide Registry Study
This multicenter study of 195 patients treated with MRI-directed, US-guided transperineal focal laser ablation revealed an in-field recurrence of clinically significant prostate cancer rate of 17% at the 1-year follow-up.
- 1 December 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (3) , e233371
MRI-directed Micro-US–guided Transperineal Focal Laser Ablation for Localized Prostate Cancer: A 1-year Follow-up Study
Multifiber micro-US–guided focal laser ablation in participants with localized prostate cancer was safe and feasible, with 18% recurrence at 1-year follow-up.
- 1 December 2024
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 313 (3) , e233371
MRI-directed Micro-US–guided Transperineal Focal Laser Ablation for Localized Prostate Cancer: A 1-year Follow-up Study
Multifiber micro-US–guided focal laser ablation in participants with localized prostate cancer was safe and feasible, with 18% recurrence at 1-year follow-up.
- 1 November 2022
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 19 (Supplement) , S17-S18
Onset of Sexuality is Impaired in Young Men with a Persistent Congenital Phimosis.
Objectives Phimosis is a narrowing of the preputial orifice that hinders complete and painless foreskin retraction onto the glans. It is physiological in children but should be resolved at puberty. Some men reach adulthood with a persistent congenital phimosis (PCP) that can impair their sexuality. The literature is abundant on circumcision, but little attention is paid to phimosis. We aimed to evaluate the impact of PCP on sexuality in early adulthood. Methods Inclusion criterae: men over 18 years of age who reached adulthood with PCP. Methods: Descriptive study based on an online questionnaire (37 questions), exploring medical history, emotional experience and sexual function (including a personal adaptation of the Sexual Complaint Screener for Males). Results 435 men were contacted, 80 completed the questionnaire, 67 were included. 79% had impaired sexual onset, 69% had significant anxiety, 66% avoided sex, and 46% avoided a romantic relationship. Desire and arousal were impaired in only 20% and 15%. Sexual function was more impaired during penetration than during masturbation, in the domains of arousal (erectile dysfunction 36% vs 13%) and orgasm (rapid ejaculation 28% vs 20%, delayed ejaculation 18% vs 3%). 67% were dyspareunic. 60% realized they had a problem before 18 years, but 82% did not seek medical advice until after 20, half of them after 25. The mode of revelation was comparison with others (porn and peers) (36%), self-observation (33%), sexual encounter (28%).There was no traumatic experience of foreskin retraction in childhood, and 55% recommended prevention in adolescents. Conclusions Biases: descriptive study, heterogeneity of the population, declarative nature of the data, absence of a control population. Nevertheless, this study is the first to show that unresolved PCP in adolescence alters penetrative but not masturbatory sexuality, leads to avoidance of romance and penetration, with delay in seeking treatment. Preventive systematic andrological consultation should be proposed to adolescents. Conflicts of Interest The authors declare no conflict of interest
- 1 November 2022
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 19 (Supplement) , S17-S18
Onset of Sexuality is Impaired in Young Men with a Persistent Congenital Phimosis.
Objectives Phimosis is a narrowing of the preputial orifice that hinders complete and painless foreskin retraction onto the glans. It is physiological in children but should be resolved at puberty. Some men reach adulthood with a persistent congenital phimosis (PCP) that can impair their sexuality. The literature is abundant on circumcision, but little attention is paid to phimosis. We aimed to evaluate the impact of PCP on sexuality in early adulthood. Methods Inclusion criterae: men over 18 years of age who reached adulthood with PCP. Methods: Descriptive study based on an online questionnaire (37 questions), exploring medical history, emotional experience and sexual function (including a personal adaptation of the Sexual Complaint Screener for Males). Results 435 men were contacted, 80 completed the questionnaire, 67 were included. 79% had impaired sexual onset, 69% had significant anxiety, 66% avoided sex, and 46% avoided a romantic relationship. Desire and arousal were impaired in only 20% and 15%. Sexual function was more impaired during penetration than during masturbation, in the domains of arousal (erectile dysfunction 36% vs 13%) and orgasm (rapid ejaculation 28% vs 20%, delayed ejaculation 18% vs 3%). 67% were dyspareunic. 60% realized they had a problem before 18 years, but 82% did not seek medical advice until after 20, half of them after 25. The mode of revelation was comparison with others (porn and peers) (36%), self-observation (33%), sexual encounter (28%).There was no traumatic experience of foreskin retraction in childhood, and 55% recommended prevention in adolescents. Conclusions Biases: descriptive study, heterogeneity of the population, declarative nature of the data, absence of a control population. Nevertheless, this study is the first to show that unresolved PCP in adolescence alters penetrative but not masturbatory sexuality, leads to avoidance of romance and penetration, with delay in seeking treatment. Preventive systematic andrological consultation should be proposed to adolescents. Conflicts of Interest The authors declare no conflict of interest
- 1 November 2022
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 19 (Supplement) , S95
Onset of Sexuality is Impaired in Young Men with a Persistent Congenital Phimosis.
Objectives Phimosisis a narrowing of the preputial orifice that hinders complete and painless foreskin retraction onto the glans. It is physiological in children but should be resolved at puberty. Some men reach adulthood with a persistent congenital phimosis (PCP) that can impair their sexuality. The literature is abundant on circumcision, but little attention is paid to phimosis. We aimed to evaluate the impact of PCP on sexuality in early adulthood. Methods Inclusion criterae: men over 18 years of age who reached adulthood with PCP. Methods: Descriptive study based on an online questionnaire (37 questions), exploring medical history, emotional experience and sexual function (including a personal adaptation of the Sexual Complaint Screener for Males). Results 435 men were contacted, 80 completed the questionnaire, 67 were included. 79% had impaired sexual onset, 69% had significant anxiety, 66% avoided sex, and 46% avoided a romantic relationship. Desire and arousal were impaired in only 20% and 15%. Sexual function was more impaired during penetration than during masturbation, in the domains of arousal (erectile dysfunction 36% vs 13%) and orgasm (rapid ejaculation 28% vs 20%, delayed ejaculation 18% vs 3%). 67% were dyspareunic. 60% realizedthey had a problem before 18 years, but 82% did not seek medical advice until after 20, half of them after 25. The mode of revelation was comparison with others (porn and peers) (36%), self-observation (33%), sexual encounter (28%).There was no traumatic experience of foreskin retraction in childhood, and 55% recommended prevention in adolescents. Conclusions Biases: descriptive study, heterogeneity of the population, declarative nature of the data, absence of a control population. Nevertheless, this study is the first to show that unresolved PCP in adolescence alters penetrative but not masturbatory sexuality, leads to avoidance of romance and penetration, with delay in seeking treatment. Preventive systematic andrological consultation should be proposed to adolescents. Conflicts of Interest The authors declare no conflict of interest
- 1 November 2022
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 19 (Supplement) , S95
Onset of Sexuality is Impaired in Young Men with a Persistent Congenital Phimosis.
Objectives Phimosisis a narrowing of the preputial orifice that hinders complete and painless foreskin retraction onto the glans. It is physiological in children but should be resolved at puberty. Some men reach adulthood with a persistent congenital phimosis (PCP) that can impair their sexuality. The literature is abundant on circumcision, but little attention is paid to phimosis. We aimed to evaluate the impact of PCP on sexuality in early adulthood. Methods Inclusion criterae: men over 18 years of age who reached adulthood with PCP. Methods: Descriptive study based on an online questionnaire (37 questions), exploring medical history, emotional experience and sexual function (including a personal adaptation of the Sexual Complaint Screener for Males). Results 435 men were contacted, 80 completed the questionnaire, 67 were included. 79% had impaired sexual onset, 69% had significant anxiety, 66% avoided sex, and 46% avoided a romantic relationship. Desire and arousal were impaired in only 20% and 15%. Sexual function was more impaired during penetration than during masturbation, in the domains of arousal (erectile dysfunction 36% vs 13%) and orgasm (rapid ejaculation 28% vs 20%, delayed ejaculation 18% vs 3%). 67% were dyspareunic. 60% realizedthey had a problem before 18 years, but 82% did not seek medical advice until after 20, half of them after 25. The mode of revelation was comparison with others (porn and peers) (36%), self-observation (33%), sexual encounter (28%).There was no traumatic experience of foreskin retraction in childhood, and 55% recommended prevention in adolescents. Conclusions Biases: descriptive study, heterogeneity of the population, declarative nature of the data, absence of a control population. Nevertheless, this study is the first to show that unresolved PCP in adolescence alters penetrative but not masturbatory sexuality, leads to avoidance of romance and penetration, with delay in seeking treatment. Preventive systematic andrological consultation should be proposed to adolescents. Conflicts of Interest The authors declare no conflict of interest
- Open Access
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 199 (4S)
PD34-06 COMPREHENSIVE EVALUATION OF COMPLICATIONS OF FOCAL THERAPY: A STANDARDIZED METHODOLOGY
- 1 April 2018
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 199 (4S)
Open AccessPD34-06 COMPREHENSIVE EVALUATION OF COMPLICATIONS OF FOCAL THERAPY: A STANDARDIZED METHODOLOGY
- Open Access
- 1 October 2017
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 43 (5) , 995-996
Focal cryotherapy: step by step technique description
Focal cryotherapy emerged as an efficient option to treat favorable and localized prostate cancer (PCa). The purpose of this video is to describe the procedure step by step. We present the case of a 68 year-old man with localized PCa in the anterior aspect of the prostate. The procedure is performed under general anesthesia, with the patient in lithotomy position. Briefly, the equipament utilized includes the cryotherapy console coupled with an ultrasound system, argon and helium gas bottles, cryoprobes, temperature probes and an urethral warming catheter. The procedure starts with a real-time trans-rectal prostate ultrasound, which is used to outline the prostate, the urethra and the rectal wall. The cryoprobes are pretested and placed in to the prostate through the perineum, following a grid template, along with the temperature sensors under ultrasound guidance. A cystoscopy confirms the right positioning of the needles and the urethral warming catheter is installed. Thereafter, the freeze sequence with argon gas is started, achieving extremely low temperatures (-40ºC) to induce tumor cell lysis. Sequentially, the thawing cycle is performed using helium gas. This process is repeated one time. Results among several series showed a biochemical disease-free survival between 71-93% at 9-70 month- follow-up, incontinence rates between 0-3.6% and erectile dysfunction between 0-42% (1-5). Focal cryotherapy is a feasible procedure to treat anterior PCa that may offer minimal morbidity, allowing good cancer control and better functional outcomes when compared to whole-gland treatment.
- 1 October 2017
- Published by FapUNIFESP (SciELO) in International braz j urol
- Vol. 43 (5) , 995-996
Open AccessFocal cryotherapy: step by step technique description
Focal cryotherapy emerged as an efficient option to treat favorable and localized prostate cancer (PCa). The purpose of this video is to describe the procedure step by step. We present the case of a 68 year-old man with localized PCa in the anterior aspect of the prostate. The procedure is performed under general anesthesia, with the patient in lithotomy position. Briefly, the equipament utilized includes the cryotherapy console coupled with an ultrasound system, argon and helium gas bottles, cryoprobes, temperature probes and an urethral warming catheter. The procedure starts with a real-time trans-rectal prostate ultrasound, which is used to outline the prostate, the urethra and the rectal wall. The cryoprobes are pretested and placed in to the prostate through the perineum, following a grid template, along with the temperature sensors under ultrasound guidance. A cystoscopy confirms the right positioning of the needles and the urethral warming catheter is installed. Thereafter, the freeze sequence with argon gas is started, achieving extremely low temperatures (-40ºC) to induce tumor cell lysis. Sequentially, the thawing cycle is performed using helium gas. This process is repeated one time. Results among several series showed a biochemical disease-free survival between 71-93% at 9-70 month- follow-up, incontinence rates between 0-3.6% and erectile dysfunction between 0-42% (1-5). Focal cryotherapy is a feasible procedure to treat anterior PCa that may offer minimal morbidity, allowing good cancer control and better functional outcomes when compared to whole-gland treatment.
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e29-e31
Low rate of positive surgical margins are not associated with improved biochemical recurrence in high-risk prostate cancer patients
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e29-e31
Low rate of positive surgical margins are not associated with improved biochemical recurrence in high-risk prostate cancer patients
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e1314-e1315
Prospective comparative analysis of oncologic and functional outcomes between focal therapy and robotic radical prostatectomy
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e1314-e1315
Prospective comparative analysis of oncologic and functional outcomes between focal therapy and robotic radical prostatectomy
- 1 July 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (6) , 133
Oncologic outcomes after hemiablation therapy for localized prostate cancer
- 1 July 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (6) , 133
Oncologic outcomes after hemiablation therapy for localized prostate cancer
- 1 July 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (6) , 135
Minimally invasive salvage prostatectomy after primary radiation or ablation treatment: Complications, functional and long-term oncological outcomes
- 1 July 2016
- Published by Elsevier in European Urology Supplements
- Vol. 15 (6) , 135
Minimally invasive salvage prostatectomy after primary radiation or ablation treatment: Complications, functional and long-term oncological outcomes